FDA Inspection 1315522 - Summit Therapeutics, Inc. - April 10, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Summit Therapeutics, Inc., with an inspection on April 10, 2026, issued by the San Francisco District Office, covering human drugs.

Company: Summit Therapeutics, Inc.
Inspection Date: April 10, 2026
Product Type: Human Drugs
Office: San Francisco District Office

Open in Dashboard

ID · e674ab87-2293-45ca-9d8d-639ba5341556